Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors

Key Points Patients with CKD show bone marrow alterations, with elevated TNF α and soluble urokinase plasminogen activator receptor (suPAR) levels and proinflammatory monocytic cells. TNF α disrupted myelopoiesis, driving metabolic, transcriptional, and epigenetic changes in monocytes that increased cytokine and soluble urokinase plasminogen activator receptor production. Secreted factors from TNF α -altered myeloid cells synergistically disrupted podocyte structure and glomerular function. Background Immune dysregulation and chronic inflammation have been implicated in the pathogenesis of CKD. Altered bone marrow hematopoiesis is commonly observed in CKD-associated conditions, such as diabetes, cardiovascular disease, and aging. However, the role of bone marrow dysfunction in CKD progression has not been thoroughly interrogated in humans. This study examines how inflammation-induced bone marrow alterations contribute to CKD progression. Methods Bone marrow aspirates were obtained from ten patients with CKD (eight with FSGS and six of whom were kidney transplant recipients) and from healthy donors. Samples were analyzed using ELISA, multiplex cytokine assays, multicolor flow cytometry, and single-cell RNA sequencing. To mimic CKD patient bone marrow alterations, in vitro myelopoiesis assays were conducted under TNF α exposure. Cellular and molecular changes were assessed using assay for transposase-accessible chromatin using sequencing, RNA sequencing, metabolic assays, flow cytometry, and cytokine analysis. We tested the in vivo effect of TNF α blockade and coinjection of TNF α with IFN γ in mice. We also measured TNF α levels in three different mouse models of proteinuria and in soluble urokinase plasminogen activator receptor (suPAR)–deficient mice. The effect of secreted factors from TNF α -driven, functionally altered myeloid cells on kidney function was evaluated using high-throughput immunofluorescence assays on cultured podocytes and filtration function assays in zebrafish. Results Bone marrow from patients with CKD exhibited elevated TNF α and suPAR levels, along with inflammatory transcriptomic profiles in monocytic cells. TNF α -driven myelopoiesis in vitro induced altered monocytic cells resembling those in patients with CKD. These cells displayed increased metabolic activity, transcriptional and epigenetic reprogramming, and elevated secretion of proinflammatory cytokines and suPAR. In a cooperative manner, these secreted factors caused filtration dysfunction in zebrafish and led to cytoskeletal disarrangement in cultured podocytes. In mice, TNF α exposure during myelopoiesis resulted in increased suPAR levels and proteinuria. Conclusions TNF α -driven alterations in bone marrow monocytic cells contribute to glomerular dysfunction in CKD, suggesting bone marrow dysfunction as a central upstream driver of CKD. Podcast This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2025_12_02_ASN0000000828.mp3